Angelyn Anton

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Squamous Cell Carcinoma

Radical Prostatectomy

Top Venues

Expert review of pharmacoeconomics & outcomes research

JCO oncology practice

BJU international

This page only lists publications with an associated author ORCID identifier.

Publications

Ying Yan Zhong, Angelyn Anton, Owen Xie, Natalie Tan, Sophie O'Haire, Sam Maleki, Andrisha-Jade Inderjeeth, Phillip Parente, Lavinia Spain, Peter Gibbs, Ben Tran
Impact of Comorbidities and Drug Interactions in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors. JCO oncology practice (2024)
Ying Yan Zhong, Angelyn Anton, Owen Xie, Natalie Tan, Sophie O'Haire, Sam Maleki, Andrisha-Jade Inderjeeth, Phillip Parente, Lavinia Spain, Peter Gibbs, Ben Tran
Impact of Comorbidities and Drug Interactions in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors. JCO oncology practice (2024)
Amanda Pereira-Salgado, Angelyn Anton, Fanny Franchini, Robert K Mahar, Edmond M Kwan, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun A Azad, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Christopher Steer, Stephen Brown, Peter Gibbs, Ben Tran, Maarten IJzerman
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor targeted agents matter? Expert review of pharmacoeconomics & outcomes research (2022)
Ciara Conduit, Christina Guo, Allan 'Ben' Smith, Orlando Rincones, Olivia Nina Baenziger, Benjamin C Thomas, Jeremy Goad, Dan Lenaghan, Nathan L Lawrentschuk, Lih-Ming Wong, Niall M Corcoran, Margaret Ross, Peter Gibbs, Sophie O'Haire, Angelyn Anton, Elizabeth Liow, Jeremy H Lewin, Ben Tran
Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods Study. JMIR cancer 8 (4) (2022)
Amanda Pereira-Salgado, Angelyn Anton, Fanny Franchini, Robert K Mahar, Edmond M Kwan, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun A Azad, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Christopher Steer, Stephen Brown, Peter Gibbs, Ben Tran, Maarten IJzerman
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter? Expert review of pharmacoeconomics & outcomes research (2022)
Amanda Pereira-Salgado, Angelyn Anton, Fanny Franchini, Robert K Mahar, Edmond M Kwan, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun A Azad, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Christopher Steer, Stephen Brown, Peter Gibbs, Ben Tran, Maarten IJzerman
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter? Expert review of pharmacoeconomics & outcomes research 23 (2) (2022)
Amanda Pereira-Salgado, Angelyn Anton, Fanny Franchini, Robert K Mahar, Edmond M Kwan, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun A Azad, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Christopher Steer, Stephen Brown, Peter Gibbs, Ben Tran, Maarten IJzerman
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter? Expert review of pharmacoeconomics & outcomes research 23 (2) (2022)
Angelyn Anton, Ben Tran
Global Disparity in Access to Novel Therapeutics for Metastatic Prostate Cancer. JCO oncology practice (2021)
Richard Kelly, Angelyn Anton, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun A Azad, Edmond Michael Kwan, Lavinia Spain, Arun Muthusamy, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Anthony Joshua, David Pook, Olivia Baenziger, Peter Gibbs, Ben Tran
Real-world use of first-generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration-resistant prostate cancer. BJU international (2021)
Angelyn Anton, Sruti Pillai, Marie Christine Semira, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun A Azad, Edmond M Kwan, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Olivia Baenziger, Peter Gibbs, Ben Tran
Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer. BJUI compass 3 (3) (2021)
Angelyn Anton, Olfat Kamel Hasan, Zita Ballok, Patrick Bowden, Anthony J Costello, Laurence Harewood, Niall M Corcoran, Phil Dundee, Justin S Peters, Nathan L Lawrentschuk, Andrew Troy, David Webb, Yee Chan, Andrew See, Shankar Siva, Declan G Murphy, Michael S Hofman, Ben Tran
Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer. BJU international 126 (4) (2020)